Skip to main content

Paula Tagliani

Institutions of which they are part

Predoctoral researcher
Clinical Neuroimmunology
Vall Hebron Institut de Recerca

Paula Tagliani

Institutions of which they are part

Predoctoral researcher
Clinical Neuroimmunology
Vall Hebron Institut de Recerca

Related news

A study conducted at the Catalan Multiple Sclerosis Centre (Cemcat) shows that the lack of a reduction in neurofilament light chain during the first year of treatment is associated with a higher risk of subsequent disease activity.

The project’s 4th annual meeting was recently held as part of the Fortalece–Salud programme of the Carlos III Health Institute.

An international study led by researchers from Vall d’Hebron shows that simple tests that patients can perform themselves help detect changes in disability that may occur even in the absence of disease relapses.

Related professionals

Maria Luisa Pancorbo Lerma

Maria Luisa Pancorbo Lerma

Predoctoral researcher
Maternal and Fetal Medicine
Read more
Pau Sarle Valles

Pau Sarle Valles

Predoctoral researcher
Neurodegenerative Diseases
Read more
Maria Llorian Salvador

Maria Llorian Salvador

Main researcher
Diabetes and Metabolism
Read more
Jose  Antonio Bernabeu Garcia

Jose Antonio Bernabeu Garcia

Predoctoral researcher
Physical Medicine and Rehabilitation
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.